Login / Signup

The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial.

Maryam JarhahzadehPezhman AlavinejadFarnaz FarsiDurdana HusainAfshin Rezazadeh
Published in: Diabetology & metabolic syndrome (2021)
In conclusion this study suggests that daily consumption of turmeric (and its active phenolic ingredients as curcumin) supplementation could be effective in management of NAFLD and decreasing serum level of liver transaminases.
Keyphrases
  • clinical trial
  • double blind
  • phase ii
  • study protocol
  • placebo controlled
  • physical activity
  • open label